EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burden of hepatitis B virus-associated liver cancer in Asia: findings from the global burden of disease study

Xin-Jing Yang, Xue-Qi Yang, Xuan-Ying Mo, Jing Zuo, Yu-Chen Fan

Frontiers in Public Health · 23.04.2026 · 14

DOI: 10.3389/fpubh.2026.1805052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 23.04.2026. Verfasst von Xin-Jing Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Global Burden of Disease, Hepatitis B, Chronic. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis B virus (HBV) infection is widespread in Asia. Of the many chronic diseases linked to HBV, among the most important is liver cancer. This study analysed the disease burden of chronic hepatitis B-associated liver cancer in Asia from 1990 to 2021.

Methods

Data were obtained from the 2021 Global Burden of Disease study. We analyzed incidence, prevalence, deaths and disability-adjusted life years (DALYs) in Asian regions and countries from 1990 to 2021 by age and sex. Data processing and graph construction were performed using RStudio and BioWinford. The Joinpoint regression model was used to analyse the temporal data trends.

Results

From 1990 to 2021, the disease burden of hepatitis B-related liver cancer in Asia decreased. A decline was observed in the rates of incidence (AAPC: −0.6), prevalence (AAPC: −0.1), deaths (AAPC: −1.0), and DALYs (AAPC: −1.2), even though their absolute numbers all increased. The number of incidence, prevalence, deaths and DALYs is highest among the middle-aged and older adults, and the highest rate is found among the older adults. Both the number and rate are highest in East Asia. Disease burdens differ by country.

Discussion

The burden of hepatitis B-associated liver cancer in Asia has decreased over the past three decades, but remains non-negligible. Asian countries need to take corresponding measures against hepatitis B.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsGlobal Burden of DiseaseHepatitis B, ChronicHumansAsiaIncidenceFemaleDisability-Adjusted Life YearsPrevalenceMaleMiddle AgedAdultAgedYoung AdultAdolescent

Stichwörter der Autor:innen

AsiaJoinpoint modelglobal burden of diseasehepatitis Bliver cancer

Autor:innen und Institutionen

  • Department of Hepatology, Qilu Hospital of Shandong University, Jinan, China.
  • Hepatology Institute of Shandong University, Jinan, China.

Zitieren

APA

Yang, X. J., Yang, X. Q., Mo, X. Y., Zuo, J., & Fan, Y. C. (2026). Burden of hepatitis B virus-associated liver cancer in Asia: findings from the global burden of disease study. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1805052

Vancouver

Yang XJ, Yang XQ, Mo XY, Zuo J, Fan YC. Burden of hepatitis B virus-associated liver cancer in Asia: findings from the global burden of disease study. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1805052

BibTeX
@article{Yang2026,
  author = {Yang, Xin-Jing and Yang, Xue-Qi and Mo, Xuan-Ying and Zuo, Jing and Fan, Yu-Chen},
  title = {Burden of hepatitis B virus-associated liver cancer in Asia: findings from the global burden of disease study},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1805052}
}
Kostenlos starten →